Acne Vulgaris Treatment Market
Table of Contents
Global Acne Vulgaris Treatment Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Acne Vulgaris Treatment Market by Value
2.2.1 Global Acne Vulgaris Treatment Revenue by Type
2.2.2 Global Acne Vulgaris Treatment Market by Value
2.3 Global Acne Vulgaris Treatment Market by Sales
2.3.1 Global Acne Vulgaris Treatment Sales by Type
2.3.2 Global Acne Vulgaris Treatment Market by Sales
3. The Major Driver of Acne Vulgaris Treatment Industry
3.1 Historical & Forecast Global Acne Vulgaris Treatment Sales and Revenue (2018-2028)
3.2 Largest Application for Acne Vulgaris Treatment (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Acne Vulgaris Treatment Market
4.1 Regional Market Size in Terms of Sales (2022 & 2028)
4.2 Regional Market Share in Terms of Revenue (2022 & 2028)
4.3 Concentration Ratio (CR5& CR10) of Acne Vulgaris Treatment Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Acne Vulgaris Treatment Sales (2018-2028)
5.1 Current and Estimated Sales Breakdown by Type (2018-2028)
5.2 Current and Estimated Sales Breakdown by Application (2018-2028)
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Acne Vulgaris Treatment Sales (2018-2028)
6.1 Current and Estimated Sales Breakdown by Type (2018-2028)
6.2 Current and Estimated Sales Breakdown by Application (2018-2028)
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Acne Vulgaris Treatment Sales (2018-2028)
7.1 Current and Estimated Sales Breakdown by Type (2018-2028)
7.2 Current and Estimated Sales Breakdown by Application (2018-2028)
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Acne Vulgaris Treatment Sales (2018-2028)
8.1 Current and Estimated Sales Breakdown by Type (2018-2028)
8.2 Current and Estimated Sales Breakdown by Application (2018-2028)
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Acne Vulgaris Treatment Sales (2018-2028)
9.1 Current and Estimated Sales Breakdown by Type (2018-2028)
9.2 Current and Estimated Sales Breakdown by Application (2018-2028)
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Acne Vulgaris Treatment Sales (2018-2028)
10.1 Current and Estimated Sales Breakdown by Type (2018-2028)
10.2 Current and Estimated Sales Breakdown by Application (2018-2028)
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Acne Vulgaris Treatment Sales (2018-2028)
11.1 Current and Estimated Sales Breakdown by Type (2018-2028)
11.2 Current and Estimated Sales Breakdown by Application (2018-2028)
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. South America Acne Vulgaris Treatment Sales (2018-2028)
12.1 Current and Estimated Sales Breakdown by Type (2018-2028)
12.2 Current and Estimated Sales Breakdown by Application (2018-2028)
12.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
12.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
13. Global Acne Vulgaris Treatment Average Price Trend
13.1 Market Price for Each Type of Acne Vulgaris Treatment in US (2018-2022)
13.2 Market Price for Each Type of Acne Vulgaris Treatment in Europe (2018-2022)
13.3 Market Price for Each Type of Acne Vulgaris Treatment in China (2018-2022)
13.4 Market Price for Each Type of Acne Vulgaris Treatment in Japan (2018-2022)
13.5 Market Price for Each Type of Acne Vulgaris Treatment in India (2018-2022)
13.6 Market Price for Each Type of Acne Vulgaris Treatment in Korea (2018-2022)
13.7 Market Price for Each Type of Acne Vulgaris Treatment in Southeast Asia (2018-2022)
13.8 Market Price for Each Type of Acne Vulgaris Treatment in South America (2018-2022)
14. Industrial Chain (Impact of COVID-19)
14.1 Acne Vulgaris Treatment Industrial Chain Analysis
14.2 Downstream
14.3 Impact of COVID-19
14.4 Post-pandemic Era
14.5 Technology Trends of Acne Vulgaris Treatment
15. Acne Vulgaris Treatment Competitive Landscape
15.1 Common Pharma Inc
15.1.1 Common Pharma Inc Company Profiles
15.1.2 Common Pharma Inc Product Introduction
15.1.3 Common Pharma Inc Acne Vulgaris Treatment Sales, Revenue (2018-2022)
15.1.4 Strategic initiatives
15.2 Cutanea Life Sciences Inc
15.2.1 Cutanea Life Sciences Inc Company Profiles
15.2.2 Cutanea Life Sciences Inc Product Introduction
15.2.3 Cutanea Life Sciences Inc Acne Vulgaris Treatment Sales, Revenue (2018-2022)
15.2.4 Strategic initiatives
15.3 Dermira Inc
15.3.1 Dermira Inc Company Profiles
15.3.2 Dermira Inc Product Introduction
15.3.3 Dermira Inc Acne Vulgaris Treatment Sales, Revenue (2018-2022)
15.3.4 Strategic initiatives
15.4 ELORAC Inc
15.4.1 ELORAC Inc Company Profiles
15.4.2 ELORAC Inc Product Introduction
15.4.3 ELORAC Inc Acne Vulgaris Treatment Sales, Revenue (2018-2022)
15.4.4 Strategic initiatives
15.5 Ensol Biosciences Inc
15.5.1 Ensol Biosciences Inc Company Profiles
15.5.2 Ensol Biosciences Inc Product Introduction
15.5.3 Ensol Biosciences Inc Acne Vulgaris Treatment Sales, Revenue (2018-2022)
15.5.4 Strategic initiatives
15.6 Foamix Pharmaceuticals Ltd
15.6.1 Foamix Pharmaceuticals Ltd Company Profiles
15.6.2 Foamix Pharmaceuticals Ltd Product Introduction
15.6.3 Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Sales, Revenue (2018-2022)
15.6.4 Strategic initiatives
15.7 Galderma SA
15.7.1 Galderma SA Company Profiles
15.7.2 Galderma SA Product Introduction
15.7.3 Galderma SA Acne Vulgaris Treatment Sales, Revenue (2018-2022)
15.7.4 Strategic initiatives
15.8 GlaxoSmithKline Plc
15.8.1 GlaxoSmithKline Plc Company Profiles
15.8.2 GlaxoSmithKline Plc Product Introduction
15.8.3 GlaxoSmithKline Plc Acne Vulgaris Treatment Sales, Revenue (2018-2022)
15.8.4 Strategic initiatives
15.9 Helix BioMedix Inc
15.9.1 Helix BioMedix Inc Company Profiles
15.9.2 Helix BioMedix Inc Product Introduction
15.9.3 Helix BioMedix Inc Acne Vulgaris Treatment Sales, Revenue (2018-2022)
15.9.4 Strategic initiatives
15.10 Hovione FarmaCiencia SA
15.10.1 Hovione FarmaCiencia SA Company Profiles
15.10.2 Hovione FarmaCiencia SA Product Introduction
15.10.3 Hovione FarmaCiencia SA Acne Vulgaris Treatment Sales, Revenue (2018-2022)
15.10.4 Strategic initiatives
15.11 Lee's Pharmaceutical Holdings Ltd
15.12 LEO Pharma A/S
15.13 Novabiotics Ltd
15.14 Novan Inc
15.15 Novartis AG
15.16 Paratek Pharmaceuticals Inc
15.17 Pfizer Inc
15.18 Phosphagenics Ltd
16. Conclusion
17. Methodology and Data Source
List of Tables and Figures
Figure 1. Total Sales by Application of Acne Vulgaris Treatment Industry (Volume)
Figure 2. Acne Vulgaris Treatment Sales by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2028)
Figure 4. The Top 10 and 5 Players Market Share by Acne Vulgaris Treatment Revenue in 2022
Figure 5. US Acne Vulgaris Treatment Sales (2018-2028)
Figure 6. Sales Breakdown by Type (%)
Figure 7. Sales Breakdown by Type (%)
Figure 8. Sales Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Acne Vulgaris Treatment Sales (2018-2028)
Figure 12. Sales Breakdown by Type (%)
Figure 13. Sales Breakdown by Type (%)
Figure 14. Sales Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Acne Vulgaris Treatment Sales (2018-2028)
Figure 18. Sales Breakdown by Type (%)
Figure 19. Sales Breakdown by Type (%)
Figure 20. Sales Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Acne Vulgaris Treatment Sales (2018-2028)
Figure 25. Sales Breakdown by Type (%)
Figure 26. Sales Breakdown by Type (%)
Figure 27. Sales Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Acne Vulgaris Treatment Sales (2018-2028)
Figure 31. Sales Breakdown by Type (%)
Figure 32. Sales Breakdown by Type (%)
Figure 33. Sales Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Acne Vulgaris Treatment Sales (2018-2028)
Figure 37. Sales Breakdown by Type (%)
Figure 38. Sales Breakdown by Type (%)
Figure 39. Sales Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Acne Vulgaris Treatment Sales (2018-2028)
Figure 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Figure 44. Sales Breakdown by Type (%)
Figure 45. Sales Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Acne Vulgaris Treatment Revenue, by Type (Million USD) (2018-2028)
Table 4. Acne Vulgaris Treatment Sales, by Type (K Unit) (2018-2028)
Table 5. Acne Vulgaris Treatment Sales (K Unit) by Application (2018-2028)
Table 6. Acne Vulgaris Treatment Sales (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Sales (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2028)
Table 10. Ranking of Global Top Acne Vulgaris Treatment Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Acne Vulgaris Treatment Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 13. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 14. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 15. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Acne Vulgaris Treatment Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 19. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 20. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 21. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Acne Vulgaris Treatment Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 25. Table Current and Estimated Sales Breakdown by Type
Table 26. Current and Estimated Sales Breakdown by Type
Table 27. Current and Estimated Sales Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Acne Vulgaris Treatment Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 30. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 31. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 32. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Acne Vulgaris Treatment Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 36. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 37. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 38. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Acne Vulgaris Treatment Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 42. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 44. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Acne Vulgaris Treatment Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 48. Table Current and Estimated Sales Breakdown by Type (2018-2028)
Table 49. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Acne Vulgaris Treatment in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Acne Vulgaris Treatment in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Acne Vulgaris Treatment in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Acne Vulgaris Treatment in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Acne Vulgaris Treatment in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Acne Vulgaris Treatment in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Acne Vulgaris Treatment in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Common Pharma Inc Profiles
Table 61. Common Pharma Inc Acne Vulgaris Treatment Product Introduction
Table 62. Common Pharma Inc Acne Vulgaris Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 63. Common Pharma Inc Strategic initiatives
Table 64. Cutanea Life Sciences Inc Profiles
Table 65. Cutanea Life Sciences Inc Acne Vulgaris Treatment Product Introduction
Table 66. Cutanea Life Sciences Inc Acne Vulgaris Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 67. Cutanea Life Sciences Inc Strategic initiatives
Table 68. Dermira Inc Profiles
Table 69. Dermira Inc Acne Vulgaris Treatment Product Introduction
Table 70. Dermira Inc Acne Vulgaris Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 71. Dermira Inc Strategic initiatives
Table 72. ELORAC Inc Profiles
Table 73. ELORAC Inc Acne Vulgaris Treatment Product Introduction
Table 74. ELORAC Inc Acne Vulgaris Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 75. ELORAC Inc Strategic initiatives
Table 76. Ensol Biosciences Inc Profiles
Table 77. Ensol Biosciences Inc Acne Vulgaris Treatment Product Introduction
Table 78. Ensol Biosciences Inc Acne Vulgaris Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 79. Ensol Biosciences Inc Strategic initiatives
Table 80. Foamix Pharmaceuticals Ltd Profiles
Table 81. Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Product Introduction
Table 82. Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 83. Foamix Pharmaceuticals Ltd Strategic initiatives
Table 84. Galderma SA Profiles
Table 85. Galderma SA Acne Vulgaris Treatment Product Introduction
Table 86. Galderma SA Acne Vulgaris Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 87. Galderma SA Strategic initiatives
Table 88. GlaxoSmithKline Plc Profiles
Table 89. GlaxoSmithKline Plc Acne Vulgaris Treatment Product Introduction
Table 90. GlaxoSmithKline Plc Acne Vulgaris Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 91. GlaxoSmithKline Plc Strategic initiatives
Table 92. Helix BioMedix Inc Profiles
Table 93. Helix BioMedix Inc Acne Vulgaris Treatment Product Introduction
Table 94. Helix BioMedix Inc Acne Vulgaris Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 95. Helix BioMedix Inc Strategic initiatives
Table 97. Hovione FarmaCiencia SA Profiles
Table 98. Hovione FarmaCiencia SA Acne Vulgaris Treatment Product Introduction
Table 99. Hovione FarmaCiencia SA Acne Vulgaris Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 100. Hovione FarmaCiencia SA Strategic initiatives
Table 101. Lee's Pharmaceutical Holdings Ltd Profiles
Table 102. Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Product Introduction
Table 103. Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 104. Lee's Pharmaceutical Holdings Ltd Strategic initiatives
Table 105. LEO Pharma A/S Profiles
Table 106. LEO Pharma A/S Acne Vulgaris Treatment Product Introduction
Table 107. LEO Pharma A/S Acne Vulgaris Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 108. LEO Pharma A/S Strategic initiatives
Table 109. Novabiotics Ltd Profiles
Table 110. Novabiotics Ltd Acne Vulgaris Treatment Product Introduction
Table 111. Novabiotics Ltd Acne Vulgaris Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 112. Novabiotics Ltd Strategic initiatives
Table 113. Novan Inc Profiles
Table 114. Novan Inc Acne Vulgaris Treatment Product Introduction
Table 115. Novan Inc Acne Vulgaris Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 116. Novan Inc Strategic initiatives
Table 117. Novartis AG Profiles
Table 118. Novartis AG Acne Vulgaris Treatment Product Introduction
Table 119. Novartis AG Acne Vulgaris Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 120. Novartis AG Strategic initiatives
Table 121. Paratek Pharmaceuticals Inc Profiles
Table 122. Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Product Introduction
Table 123. Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 124. Paratek Pharmaceuticals Inc Strategic initiatives
Table 125. Pfizer Inc Profiles
Table 126. Pfizer Inc Acne Vulgaris Treatment Product Introduction
Table 127. Pfizer Inc Acne Vulgaris Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 128. Pfizer Inc Strategic initiatives
Table 129. Phosphagenics Ltd Profiles
Table 130. Phosphagenics Ltd Acne Vulgaris Treatment Product Introduction
Table 131. Phosphagenics Ltd Acne Vulgaris Treatment Sales (Unit), Revenue (Million USD) (2018-2022)
Table 132. Phosphagenics Ltd Strategic initiatives
Industry Market Size
